InvestorsHub Logo
Followers 88
Posts 5985
Boards Moderated 0
Alias Born 03/19/2007

Re: ksuave post# 19215

Friday, 12/19/2014 1:57:22 PM

Friday, December 19, 2014 1:57:22 PM

Post# of 97085
Trying convulsive to build a Story about something which had nothing to do with DECN and or Pharmatech.

Case closed and even published with a press-release.

The recent FDA letter was singularly directed to Shasta Technologies LLC. No other company was included, either, directly or indirectly. PharmaTech was in full agreement with the FDA in its criticism of the deficiencies of the Shasta quality procedures and monitoring system. That shared opinion significantly contributed to the acquisition of GenStrip and the immediate quality and regulatory oversight that is now provided by PharmaTech.

Shasta during this period did not belong to Pharma-Tech or DECN. They had a simple licence Agreement. I would guess that everybody knows the difference between being a licensee or the owner. Today, Pharmatech is the owner and Pharmatech is controlled by DECN.